Gladstone NOW: The Campaign Join Us on the Journey ✕
61 - 75 of 120 Results Clear All
The Wall Street Journal—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, stresses wearing a mask as one of the most important things people can do right now to bring the spread of the coronavirus under control.
Gladstone Experts COVID-19 Virology Ott Lab
Screening potential COVID-19 drug therapies through lung organoids promises a faster pipeline to approved treatments.
Gladstone Experts COVID-19 Virology Krogan Lab Ott Lab Organoids
San Francisco Chronicle—Gladstone Senior Investigators Melanie Ott and Warner Greene explain the potential risks and benefits of steroid treatments for COVID-19 patients.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab Ott Lab
San Francisco Chronicle—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, comments on the recent report that dexamethasone, a common anti-inflammatory drug, reduces the death rate of severely ill COVID-19 patients by one third.
Gladstone Experts COVID-19 Virology Ott Lab
HIV establishes latency by co-opting a cellular stress pathway
News Release Research (Publication) Flow Cytometry Core HIV/AIDS Virology Ott Lab
Melanie Ott tackles emerging viruses and infectious diseases at the helm of the new Gladstone Institute of Virology
History Institutional News COVID-19 Virology Ott Lab
The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.
Gladstone Experts COVID-19 Virology Ott Lab
SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.
Gladstone Experts COVID-19 Virology Ott Lab
The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.
Gladstone Experts COVID-19 Virology Ott Lab
As Gladstone scientists are moving to study COVID-19, urgent funding is needed to support their efforts.
Donor Stories COVID-19 Virology Ott Lab
While many are working from home, these scientists are continuing to go to the lab in hopes of making a discovery that could lead to the end of the COVID-19 pandemic.
Gladstone Experts Graduate Students and Postdocs COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab McDevitt Lab Ott Lab
San Francisco Chronicle—Gladstone announced the formation of two new institutes that will shape the future of infectious disease research. Senior Investigator Melanie Ott with take the helm of the newly formed Gladstone Institute of Virology, and Senior Investigator Alexander Marson will direct the Gladstone-UCSF Institute of Genomic Immunology.
Institutional News Genomic Immunology Virology Marson Lab Ott Lab
Biocentury—Gladstone announced the formation of two new institutes: the Gladstone Institute of Virology, which will focus on COVID-19 and other emerging viruses, and the Gladstone-UCSF Institute of Genomic Immunology, which will focus on approaches to manipulate the immune system to fight cancer, autoimmune disease, and infectious disease.
Institutional News Genomic Immunology Virology Marson Lab Ott Lab
The Stem Cellar—Gladstone announced the formation of two new institutes: the Gladstone Institute of Virology, which will focus on COVID-19 and other emerging viruses, and the Gladstone-UCSF Institute of Genomic Immunology, which will focus on approaches to manipulate the immune system to fight cancer, autoimmune disease, and infectious disease. The Institute of Virology will be led by Melanie Ott, and the Institute of Genomic Immunology will be led by Alexander Marson.
Institutional News Genomic Immunology Virology Marson Lab Ott Lab
San Francisco Business Times—Gladstone recently announced the formation of two new institutes: the Gladstone Institute of Virology, which will be directed by Melanie Ott, and the Gladstone-UCSF Institute of Genomic Immunology, which will be led by Alexander Marson.
Institutional News Genomic Immunology Virology Marson Lab Ott Lab
